PL352763A1 - Somatostatin agonists - Google Patents

Somatostatin agonists

Info

Publication number
PL352763A1
PL352763A1 PL00352763A PL35276300A PL352763A1 PL 352763 A1 PL352763 A1 PL 352763A1 PL 00352763 A PL00352763 A PL 00352763A PL 35276300 A PL35276300 A PL 35276300A PL 352763 A1 PL352763 A1 PL 352763A1
Authority
PL
Poland
Prior art keywords
somatostatin agonists
somatostatin
agonists
Prior art date
Application number
PL00352763A
Other languages
Polish (pl)
Inventor
Barry A. Morgan
Dean Sadat-Aalaee
Original Assignee
Societe De Conseils De Recherches Et D'applications Scientifiques Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe De Conseils De Recherches Et D'applications Scientifiques Sas filed Critical Societe De Conseils De Recherches Et D'applications Scientifiques Sas
Publication of PL352763A1 publication Critical patent/PL352763A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PL00352763A 1999-06-25 2000-06-23 Somatostatin agonists PL352763A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14102899P 1999-06-25 1999-06-25
PCT/US2000/017401 WO2001000676A1 (en) 1999-06-25 2000-06-23 Somatostatin agonists

Publications (1)

Publication Number Publication Date
PL352763A1 true PL352763A1 (en) 2003-09-08

Family

ID=22493842

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352763A PL352763A1 (en) 1999-06-25 2000-06-23 Somatostatin agonists

Country Status (14)

Country Link
EP (1) EP1189942A1 (en)
JP (1) JP4041311B2 (en)
CN (1) CN1367792A (en)
AR (1) AR024463A1 (en)
AU (1) AU770958B2 (en)
BR (1) BR0011919A (en)
CA (1) CA2377265A1 (en)
CZ (1) CZ20014534A3 (en)
HU (1) HUP0201696A3 (en)
IL (1) IL146941A0 (en)
MX (1) MXPA01013127A (en)
PL (1) PL352763A1 (en)
RU (1) RU2263677C2 (en)
WO (1) WO2001000676A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60220157T2 (en) * 2001-03-06 2008-01-17 Il Consorzio Ferrara Richerche PROCESS FOR MODULATING THE PROLIFERATION OF MEDULLARY THYROID CARCINOMA CELLS
WO2003057214A1 (en) 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
EP2142257A2 (en) * 2007-04-30 2010-01-13 Technion Research & Development Foundation Ltd. Anticancerous polymeric agents
EP2152289A1 (en) 2007-04-30 2010-02-17 Technion Research & Development Foundation Ltd. Novel antimicrobial agents
BR112012011787B1 (en) * 2009-11-23 2022-03-03 Palatin Technologies, Inc Cyclic peptide and pharmaceutical composition
WO2011151782A1 (en) 2010-06-02 2011-12-08 Preglem Sa A role for somatostatin to modulate initiation of follicular growth in the human ovary
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083305B1 (en) * 1981-12-24 1985-07-10 Ciba-Geigy Ag Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
MD1591B2 (en) * 1993-08-09 2001-01-31 Biomeasure, Inc. Peptides derivatives possessing therapeutic activity
IL130166A0 (en) * 1996-12-04 2000-06-01 Sod Conseils Rech Applic Somatostatin antagonists
DE69812084T2 (en) * 1997-05-01 2003-12-24 Cedars Sinai Medical Center METHOD FOR TREATING HYPERPROLACTINEMIA AND PROLACTINOMA
EP0981363B1 (en) * 1997-05-13 2003-07-30 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Somatostatin agonists for decreasing body weight
WO1998051330A1 (en) * 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
WO1998051332A1 (en) * 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x

Also Published As

Publication number Publication date
CZ20014534A3 (en) 2002-06-12
HUP0201696A2 (en) 2002-09-28
HUP0201696A3 (en) 2002-10-28
EP1189942A1 (en) 2002-03-27
AU6200000A (en) 2001-01-31
RU2263677C2 (en) 2005-11-10
WO2001000676A1 (en) 2001-01-04
BR0011919A (en) 2002-03-19
AU770958B2 (en) 2004-03-11
JP2003503369A (en) 2003-01-28
JP4041311B2 (en) 2008-01-30
CN1367792A (en) 2002-09-04
AR024463A1 (en) 2002-10-02
CA2377265A1 (en) 2001-01-04
IL146941A0 (en) 2002-08-14
MXPA01013127A (en) 2002-11-04

Similar Documents

Publication Publication Date Title
EP1023061A4 (en) Somatostatin agonists
EP0977751A4 (en) Somatostatin agonists
EP0984779A4 (en) Somatostatin agonists
HK1154584A1 (en) Beta2-adrenoceptor agonists
EP1134475A4 (en) Quick connector
IL149617A0 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
IL148218A0 (en) New phenylpiperazines
IL158051A0 (en) Somatostatin agonists
GB0015517D0 (en) Somatostatin agonists
PL352763A1 (en) Somatostatin agonists
DE60044882D1 (en) Ie
PL353372A1 (en) Substituted heterocyclyl-2h-chromenes
IL144355A0 (en) 5-ht1f agonists
DE50012999D1 (en) Stirnwandisolation
GB9905235D0 (en) Connection
GB9914798D0 (en) Ensure
AU141428S (en) Turnpiece
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
GB9903377D0 (en) Amphibious-tricycle (amphi-trike)
GB2347798B (en) Lampholders
GB9806697D0 (en) Somatostatin agonists
GB9918373D0 (en) Molliboard (floodbarrier)
GB9925259D0 (en) Knock-back
GB9912122D0 (en) Leads

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)